Topical 5-aminolevulinic acid photodynamic therapy as a treatment modality for nonmelanoma skin cancer;A terapia fotodinâmica com ácido 5-aminolevulínico como modalidade de tratamento para neoplasias cutâneas não-melanoma

Anais Brasileiros de Dermatologia

Volumn 83, Issue 4, 2008, Pages 309-316

  De Felício, Lília Bernardini Antunes ^a,b   Ferreira, Juliana ^b   Bentley, Maria Vitória Badra ^b   Bagnato, Vanderlei Salvador ^b   Tedesco, Cláudio Antonio ^b   Souza, Cacilda Da Silva ^b  

^a Departamento de Clínica Médica

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aminolevulinic acid; Photochemotherapy; Skin neoplasms; Spectrometry, fluorescence

Indexed keywords

ALASENS; AMINOLEVULINIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; BURNING SENSATION; CLINICAL ARTICLE; DIODE LASER; DRUG EFFECT; DRUG RESPONSE; EDEMA; EROSION; ERYTHEMA; FEMALE; HUMAN; MALE; PHOTODYNAMIC THERAPY; SKIN CANCER; TREATMENT OUTCOME; WOUND HEALING;

EID: 55249111302     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962008000400004     Document Type: Article

References (30)

1. Daniell MD, Hill JS. A history of photodynamic therapy. Aust N Z J Surg. 1991;61:340-8.
2. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978;38:2628-35.
3. Dougherty TJ, Gomer CG, Henderson BW, Jori G, Kessel D, Korbelik M, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90:889-905.
4. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrins IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990;6:143-8.
5. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic-therapy. J Photochem Photobiol B. 1992;14:275-92.
6. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer. 1997;79:2282-308.
7. Szeimies RM, Morton CA, Sidoroff A, Braathen LR. Photodynamic therapy for non-melanoma skin cancer. Acta Derm Venereol. 2005;85:483-90.
8. Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5:497-508.
9. Taub AF. Photodynamic therapy in dermatology: history and horizons. J Drugs Dermatol. 2004;3:S8-25.
10. Olbricht SM. Treatment of malignant cutaneous tumors. Clin Plast Surg. 1993;20:167-80.
11. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol. 2002;146:552-67.
12. Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg. 2004;30:264-71.
13. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, et al. International Society for Photodynamic Therapy in Dermatology Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol. 2007;56:125-43.
14. Ackermann G, Abels C, Baumler W, Langer S, Landthaler M, Lang EW, et al. Simulations on the selectivity of 5-aminolaevulinic acid-induced fluorescence in vivo. J Photochem Photobiol B. 1998;47:121-8.
15. Martin A, Tope WD, Grevelink JM, Starr JC, Fewkes JL, Flotte TJ, et al. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch Dermatol Res. 1995;287:665-74.
16. Peng Q, Warloe T, Moan J, Heyerdahl H, Steen HB, Nesland JM, et al. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol. 1995;62:906-13.
17. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinic-based photodynamic therapy alone and with prior curettage. Br J Dermatol. 2001;145:467-71.
18. Rhodes LE, de Rie M, Enstrom Y, Groves R, Morken T, Goulden V, et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol. 2004;140:17-23.
19. Grapengiesser S, Ericson M, Gudmundsson F, Larko O, Rosen A, Wennberg AM. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol. 2002;27:493-7.
20. Haller JC, Cairnduff F, Slack G, Schofield J, Whitehurst C, Tunstall R, et al. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol. 2000;143:1270-5.
21. Varma S, Wilson H, Kurwa HA, Gambles B, Charman C, Pearse AD, et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol. 2001;144:567-74.
22. Torezan LAR. Avaliação da eficácia da terapia fotodinâmica com ácido 5-delta aminolevulínico (ALA) tópicono carcinoma basocelular [Dissertação]. São Paulo (SP): Universidade de São Paulo; 2000.
23. Bakos RM, Bakos L, Ferlin E, Cestari T, Orlandini T, Rezende R, et al. Terapêutica fotodinâmica com ácido delta- aminolevulínico em neoplasias queratinocíticas-superficiais. An Bras Dermatol. 2003;78:197-207.
24. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B. 1995;29:53-7.
25. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolaevulinic acid: An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal ceII carcinomas? J Am Acad Dermatol. 1993;28:17-21.
26. Morton CA, MacKie RM, Whitehurst C, Moore JV, McColl JH. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol. 1998;134:248-9.
27. Soler AM, Warloe T, Tausjo J, Berner A. Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Derm Venereol. 1999;79:204-6.
28. Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol. 2000;142:338-9.
29. Cox NH, Eedy DJ, Morton CA. Guidelines for management of Bowen's disease. British Association of Dermatologists. Br J Dermatol. 1999;141:633-41.
30. Souza CS, Felício LBA, Bentley MV, Tadesco AC, Ferreira J, Karachi C, et al. Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa. Br J Dermatol. 2005;153:672-4.